{"id":2412,"date":"2026-09-07T16:16:46","date_gmt":"2026-09-07T14:16:46","guid":{"rendered":"https:\/\/www.amyloidosisalliance.org\/ensayos-clinicos\/"},"modified":"2026-10-22T15:23:26","modified_gmt":"2026-10-22T13:23:26","slug":"ensayos-clinicos","status":"publish","type":"page","link":"https:\/\/www.amyloidosisalliance.org\/es\/ensayos-clinicos\/","title":{"rendered":"Ensayos cl\u00ednicos"},"content":{"rendered":"\n<nav aria-label=\"Breadcrumb\" class=\"wp-block-group aa-breadcrumb is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"aa-inner\"><a href=\"https:\/\/www.amyloidosisalliance.org\/es\/\">Inicio<\/a><span class=\"aa-breadcrumb__sep\">\u203a<\/span><span class=\"aa-breadcrumb__current\">Ensayos cl\u00ednicos<\/span><\/div>\n<\/nav>\n\n<section class=\"wp-block-group aa-page-hero is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-page-hero__grid is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group is-layout-flow wp-block-group-is-layout-flow\">\n<p class=\"aa-overline wp-block-paragraph\">Investigaci\u00f3n<\/p>\n\n\n\n<h1 class=\"wp-block-heading\">Ensayos cl\u00ednicos<\/h1>\n\n\n\n<p class=\"aa-lead wp-block-paragraph\">Todos los estudios sobre amiloidosis que est\u00e1n reclutando, van a abrir o reclutan por invitaci\u00f3n, en cualquier parte del mundo, tomados directamente de ClinicalTrials.gov y actualizados cada d\u00eda.<\/p>\n\n\n\n<p class=\"aa-trial-warn wp-block-paragraph\"><strong>Informaci\u00f3n, no consejo m\u00e9dico.<\/strong> La Alianza no dirige estos estudios y no puede inscribirle en ellos. Si un ensayo le parece pertinente, com\u00e9ntelo con el m\u00e9dico que sigue su amiloidosis.<\/p>\n<\/div>\n\n\n\n<div class=\"wp-block-group aa-page-hero__photo is-layout-flow wp-block-group-is-layout-flow\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1707\" height=\"1707\" src=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\" alt=\"\" class=\"wp-image-1000\" srcset=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg 1707w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-300x300.jpg 300w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-1024x1024.jpg 1024w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-150x150.jpg 150w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-768x768.jpg 768w, https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766-1536x1536.jpg 1536w\" sizes=\"auto, (max-width: 1707px) 100vw, 1707px\" \/><\/figure>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n\n<section id=\"trials\" class=\"wp-block-group aa-section aa-section--cream aa-trials-page is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading\">Estudios en reclutamiento y pr\u00f3ximos<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">La lista abarca la amiloidosis AL, ATTR y AA, as\u00ed como la angiopat\u00eda amiloide cerebral. Cada ficha indica en qu\u00e9 punto se encuentra el estudio: abierto a cualquier persona que cumpla sus criterios, todav\u00eda no abierto o reservado a las personas invitadas por los investigadores. Los estudios que finalizan simplemente desaparecen de la lista.<\/p>\n\n\n<div class=\"aa-trials aa-no-reveal wp-block-aa-clinical-trials\" data-endpoint=\"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/aa\/v1\/trials\" data-page=\"0\" data-per-page=\"12\"><form class=\"aa-trial-filters\" method=\"get\" action=\"https:\/\/www.amyloidosisalliance.org\/es\/\"><p class=\"aa-trial-filters__field\"><label class=\"aa-trial-filters__label\" for=\"aa-trial-t_type\">Tipo de amiloidosis<\/label><select class=\"aa-trial-filters__select\" id=\"aa-trial-t_type\" name=\"t_type\"><option value=\"\">Todos los tipos<\/option><option value=\"attr\">ATTR (transtiretina)<\/option><option value=\"al\">AL (cadenas ligeras)<\/option><option value=\"aa\">AA (secundaria)<\/option><option value=\"caa\">Angiopat\u00eda amiloide cerebral<\/option><option value=\"unspecified\">No especificado<\/option><\/select><\/p><p class=\"aa-trial-filters__field\"><label class=\"aa-trial-filters__label\" for=\"aa-trial-t_country\">Pa\u00eds<\/label><select class=\"aa-trial-filters__select\" id=\"aa-trial-t_country\" name=\"t_country\"><option value=\"\">Todos los pa\u00edses<\/option><option value=\"Argentina\">Argentina<\/option><option value=\"Australia\">Australia<\/option><option value=\"Austria\">Austria<\/option><option value=\"Belgium\">Belgium<\/option><option value=\"Brazil\">Brazil<\/option><option value=\"Bulgaria\">Bulgaria<\/option><option value=\"Canada\">Canada<\/option><option value=\"Chile\">Chile<\/option><option value=\"China\">China<\/option><option value=\"Croatia\">Croatia<\/option><option value=\"Cyprus\">Cyprus<\/option><option value=\"Czechia\">Czechia<\/option><option value=\"Denmark\">Denmark<\/option><option value=\"Estonia\">Estonia<\/option><option value=\"Finland\">Finland<\/option><option value=\"France\">France<\/option><option value=\"Germany\">Germany<\/option><option value=\"Greece\">Greece<\/option><option value=\"Hong Kong\">Hong Kong<\/option><option value=\"Hungary\">Hungary<\/option><option value=\"Ireland\">Ireland<\/option><option value=\"Israel\">Israel<\/option><option value=\"Italy\">Italy<\/option><option value=\"Japan\">Japan<\/option><option value=\"Latvia\">Latvia<\/option><option value=\"Lithuania\">Lithuania<\/option><option value=\"Malaysia\">Malaysia<\/option><option value=\"Martinique\">Martinique<\/option><option value=\"Mexico\">Mexico<\/option><option value=\"Netherlands\">Netherlands<\/option><option value=\"New Zealand\">New Zealand<\/option><option value=\"Norway\">Norway<\/option><option value=\"Poland\">Poland<\/option><option value=\"Portugal\">Portugal<\/option><option value=\"Romania\">Romania<\/option><option value=\"Singapore\">Singapore<\/option><option value=\"Slovakia\">Slovakia<\/option><option value=\"Slovenia\">Slovenia<\/option><option value=\"South Korea\">South Korea<\/option><option value=\"Spain\">Spain<\/option><option value=\"Sweden\">Sweden<\/option><option value=\"Switzerland\">Switzerland<\/option><option value=\"Taiwan\">Taiwan<\/option><option value=\"Thailand\">Thailand<\/option><option value=\"Turkey (T\u00fcrkiye)\">Turkey (T\u00fcrkiye)<\/option><option value=\"United Kingdom\">United Kingdom<\/option><option value=\"United States\">United States<\/option><option value=\"Uruguay\">Uruguay<\/option><\/select><\/p><p class=\"aa-trial-filters__field\"><label class=\"aa-trial-filters__label\" for=\"aa-trial-t_kind\">Tipo de estudio<\/label><select class=\"aa-trial-filters__select\" id=\"aa-trial-t_kind\" name=\"t_kind\"><option value=\"\">Todos los estudios<\/option><option value=\"INTERVENTIONAL\">Intervencional (tratamiento)<\/option><option value=\"OBSERVATIONAL\">Observacional (registro, imagen)<\/option><\/select><\/p><p class=\"aa-trial-filters__field\"><label class=\"aa-trial-filters__label\" for=\"aa-trial-t_status\">Estado<\/label><select class=\"aa-trial-filters__select\" id=\"aa-trial-t_status\" name=\"t_status\"><option value=\"\">Todos los estados<\/option><option value=\"RECRUITING\">Reclutando<\/option><option value=\"NOT_YET_RECRUITING\">A\u00fan no recluta<\/option><option value=\"ENROLLING_BY_INVITATION\">Por invitaci\u00f3n<\/option><\/select><\/p><p class=\"aa-trial-filters__actions\"><button type=\"submit\" class=\"aa-trial-filters__submit\">Filtrar<\/button><a class=\"aa-trial-filters__reset\" href=\"https:\/\/www.amyloidosisalliance.org\/es\/\" hidden>Borrar los filtros<\/a><\/p><\/form><div class=\"aa-trial-results\" aria-live=\"polite\" aria-busy=\"false\"><p class=\"aa-trial-count\">Mostrando 1 a 12 de 207 ensayos<\/p><div class=\"aa-trial-grid\"><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--not-yet-recruiting\">A\u00fan no recluta<\/span><span class=\"aa-trial-type\">ATTR (transtiretina)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07538518\" target=\"_blank\" rel=\"noopener noreferrer\">PET Imaging Study Using Evuzamitide to Detect Cardiac Amyloidosis in Patients With Inconclusive Nuclear Scans and Elevated TAD1 Levels<span class=\"screen-reader-text\"> (se abre en ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The goal of this study is to learn whether PET-CT imaging using evuzamitide can help diagnose transthyretin cardiac amyloidosis (ATTR-CA) in patients whose standard\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Estudio<\/dt><dd>Observacional (registro, imagen)<\/dd><\/div><div><dt>Promotor<\/dt><dd>Lorena Saelices<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Recluta en: <\/span><span class=\"aa-trial-place\">United States<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07538518<\/span><span class=\"aa-trial-card__updated\">Actualizado el 22 octubre 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--enrolling-by-invitation\">Por invitaci\u00f3n<\/span><span class=\"aa-trial-type\">ATTR (transtiretina)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06679946\" target=\"_blank\" rel=\"noopener noreferrer\">A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy<span class=\"screen-reader-text\"> (se abre en ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The purpose of this study is to obtain safety, efficacy, and pharmacodynamic data on the use of vutrisiran in patients with ATTR amyloidosis with\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Estudio<\/dt><dd>Intervencional (tratamiento)<\/dd><\/div><div><dt>Fase<\/dt><dd>Fase 3<\/dd><\/div><div><dt>Promotor<\/dt><dd>Alnylam Pharmaceuticals<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Recluta en: <\/span><span class=\"aa-trial-place\">Argentina<\/span><span class=\"aa-trial-place\">Austria<\/span><span class=\"aa-trial-place\">Belgium<\/span><span class=\"aa-trial-place\">Brazil<\/span><span class=\"aa-trial-place aa-trial-place--more\">+13<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT06679946<\/span><span class=\"aa-trial-card__updated\">Actualizado el 21 octubre 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Reclutando<\/span><span class=\"aa-trial-type\">ATTR (transtiretina)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07207811\" target=\"_blank\" rel=\"noopener noreferrer\">CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis<span class=\"screen-reader-text\"> (se abre en ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">This study will find out if a new medicine called NNC6019-0001 can help reduce the risk of heart-related death and illness in participants with\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Estudio<\/dt><dd>Intervencional (tratamiento)<\/dd><\/div><div><dt>Fase<\/dt><dd>Fase 3<\/dd><\/div><div><dt>Promotor<\/dt><dd>Novo Nordisk A\/S<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Recluta en: <\/span><span class=\"aa-trial-place\">Argentina<\/span><span class=\"aa-trial-place\">Australia<\/span><span class=\"aa-trial-place\">Belgium<\/span><span class=\"aa-trial-place\">Brazil<\/span><span class=\"aa-trial-place aa-trial-place--more\">+16<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07207811<\/span><span class=\"aa-trial-card__updated\">Actualizado el 21 octubre 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--not-yet-recruiting\">A\u00fan no recluta<\/span><span class=\"aa-trial-type\">AL (cadenas ligeras)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07874334\" target=\"_blank\" rel=\"noopener noreferrer\">Phase 1a\/b Study of GPRC5D CART Therapy in Relapsed\/Refractory Multiple Myeloma and Light-chain Amyloidosis<span class=\"screen-reader-text\"> (se abre en ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">A Phase 1a\/b Open-Label Study to Evaluate Safety and Preliminary Efficacy of GPRC5D CART Therapy for the Treatment of Relapsed\/Refractory Multiple Myeloma and Light-chain\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Estudio<\/dt><dd>Intervencional (tratamiento)<\/dd><\/div><div><dt>Fase<\/dt><dd>Fase 1<\/dd><\/div><div><dt>Promotor<\/dt><dd>Hadassah Medical Organization<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Recluta en: <\/span><span class=\"aa-trial-place\">Israel<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07874334<\/span><span class=\"aa-trial-card__updated\">Actualizado el 20 octubre 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Reclutando<\/span><span class=\"aa-trial-type\">ATTR (transtiretina)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07052903\" target=\"_blank\" rel=\"noopener noreferrer\">TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy<span class=\"screen-reader-text\"> (se abre en ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The purpose of this study is to: * Evaluate the efficacy of nucresiran compared to placebo on reducing all-cause mortality and cardiovascular (CV) events\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Estudio<\/dt><dd>Intervencional (tratamiento)<\/dd><\/div><div><dt>Fase<\/dt><dd>Fase 3<\/dd><\/div><div><dt>Promotor<\/dt><dd>Alnylam Pharmaceuticals<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Recluta en: <\/span><span class=\"aa-trial-place\">Argentina<\/span><span class=\"aa-trial-place\">Australia<\/span><span class=\"aa-trial-place\">Austria<\/span><span class=\"aa-trial-place\">Belgium<\/span><span class=\"aa-trial-place aa-trial-place--more\">+32<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07052903<\/span><span class=\"aa-trial-card__updated\">Actualizado el 20 octubre 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Reclutando<\/span><span class=\"aa-trial-type\">ATTR (transtiretina)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07298044\" target=\"_blank\" rel=\"noopener noreferrer\">A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis<span class=\"screen-reader-text\"> (se abre en ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">Transthyretin (TTR) is a protein made by the liver that helps transport thyroid hormone and vitamin A in the blood. In some people, this\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Estudio<\/dt><dd>Intervencional (tratamiento)<\/dd><\/div><div><dt>Fase<\/dt><dd>Fase 4<\/dd><\/div><div><dt>Promotor<\/dt><dd>Bayer<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Recluta en: <\/span><span class=\"aa-trial-place\">Austria<\/span><span class=\"aa-trial-place\">Belgium<\/span><span class=\"aa-trial-place\">Germany<\/span><span class=\"aa-trial-place\">Italy<\/span><span class=\"aa-trial-place aa-trial-place--more\">+1<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07298044<\/span><span class=\"aa-trial-card__updated\">Actualizado el 15 octubre 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Reclutando<\/span><span class=\"aa-trial-type\">ATTR (transtiretina)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT04561518\" target=\"_blank\" rel=\"noopener noreferrer\">ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)<span class=\"screen-reader-text\"> (se abre en ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The purpose of this study is to: * Describe epidemiological and clinical characteristics, natural history and real-world clinical management of ATTR amyloidosis patients *\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Estudio<\/dt><dd>Observacional (registro, imagen)<\/dd><\/div><div><dt>Promotor<\/dt><dd>Alnylam Pharmaceuticals<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Recluta en: <\/span><span class=\"aa-trial-place\">Brazil<\/span><span class=\"aa-trial-place\">Bulgaria<\/span><span class=\"aa-trial-place\">Denmark<\/span><span class=\"aa-trial-place\">France<\/span><span class=\"aa-trial-place aa-trial-place--more\">+8<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT04561518<\/span><span class=\"aa-trial-card__updated\">Actualizado el 13 octubre 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Reclutando<\/span><span class=\"aa-trial-type\">No especificado<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07583823\" target=\"_blank\" rel=\"noopener noreferrer\">Elevated Rate Pacing of Cardiac Amyloidosis<span class=\"screen-reader-text\"> (se abre en ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">This study aims to better quantify the improvements in heart failure symptoms and exercise tolerance before and after the heart rate elevation in a\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Estudio<\/dt><dd>Intervencional (tratamiento)<\/dd><\/div><div><dt>Promotor<\/dt><dd>University of Minnesota<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Recluta en: <\/span><span class=\"aa-trial-place\">United States<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07583823<\/span><span class=\"aa-trial-card__updated\">Actualizado el 13 octubre 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Reclutando<\/span><span class=\"aa-trial-type\">ATTR (transtiretina)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07358078\" target=\"_blank\" rel=\"noopener noreferrer\">DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting<span class=\"screen-reader-text\"> (se abre en ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The purpose of this study is to: * Describe the clinical characteristics of adult patients with transthyretin-mediated amyloidosis with cardiomyopathy (ATTR-CM) treated with vutrisiran\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Estudio<\/dt><dd>Observacional (registro, imagen)<\/dd><\/div><div><dt>Promotor<\/dt><dd>Alnylam Pharmaceuticals<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Recluta en: <\/span><span class=\"aa-trial-place\">Germany<\/span><span class=\"aa-trial-place\">Japan<\/span><span class=\"aa-trial-place\">United States<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07358078<\/span><span class=\"aa-trial-card__updated\">Actualizado el 9 octubre 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Reclutando<\/span><span class=\"aa-trial-type\">No especificado<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07589595\" target=\"_blank\" rel=\"noopener noreferrer\">A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)<span class=\"screen-reader-text\"> (se abre en ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The main purpose of this study is to evaluate whether treatment with donanemab slows the progression of cognitive (how we think, learn, remember, pay\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Estudio<\/dt><dd>Intervencional (tratamiento)<\/dd><\/div><div><dt>Fase<\/dt><dd>Fase 2<\/dd><\/div><div><dt>Promotor<\/dt><dd>Eli Lilly and Company<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Recluta en: <\/span><span class=\"aa-trial-place\">Japan<\/span><span class=\"aa-trial-place\">South Korea<\/span><span class=\"aa-trial-place\">Taiwan<\/span><span class=\"aa-trial-place\">United States<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07589595<\/span><span class=\"aa-trial-card__updated\">Actualizado el 8 octubre 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Reclutando<\/span><span class=\"aa-trial-type\">ATTR (transtiretina)<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07235462\" target=\"_blank\" rel=\"noopener noreferrer\">A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting<span class=\"screen-reader-text\"> (se abre en ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">Transthyretin Amyloid Cardiomyopathy (ATTR-CM) is a serious and life-threatening condition where a protein called transthyretin (TTR) misfolds and builds up as amyloid fibrils in\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Estudio<\/dt><dd>Observacional (registro, imagen)<\/dd><\/div><div><dt>Promotor<\/dt><dd>Bayer<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Recluta en: <\/span><span class=\"aa-trial-place\">Austria<\/span><span class=\"aa-trial-place\">Belgium<\/span><span class=\"aa-trial-place\">Croatia<\/span><span class=\"aa-trial-place\">Denmark<\/span><span class=\"aa-trial-place aa-trial-place--more\">+13<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07235462<\/span><span class=\"aa-trial-card__updated\">Actualizado el 8 octubre 2026<\/span><\/p><\/article><article class=\"aa-trial-card\"><p class=\"aa-trial-card__flags\"><span class=\"aa-trial-status aa-trial-status--recruiting\">Reclutando<\/span><span class=\"aa-trial-type\">No especificado<\/span><\/p><h3 class=\"aa-trial-card__title\"><a href=\"https:\/\/clinicaltrials.gov\/study\/NCT07494942\" target=\"_blank\" rel=\"noopener noreferrer\">Impact of a Cardiac Rehabilitation Program on Patients With Cardiac Amyloidosis<span class=\"screen-reader-text\"> (se abre en ClinicalTrials.gov)<\/span><\/a><\/h3><p class=\"aa-trial-card__summary\">The goal of this clinical trial is to learn if a structured cardiac rehabilitation program can help people with cardiac amyloidosis improve their ability\u2026<\/p><dl class=\"aa-trial-card__facts\"><div><dt>Estudio<\/dt><dd>Intervencional (tratamiento)<\/dd><\/div><div><dt>Promotor<\/dt><dd>University Hospital, Montpellier<\/dd><\/div><\/dl><p class=\"aa-trial-card__places\"><span class=\"screen-reader-text\">Recluta en: <\/span><span class=\"aa-trial-place\">France<\/span><\/p><p class=\"aa-trial-card__foot\"><span class=\"aa-trial-card__nct\">NCT07494942<\/span><span class=\"aa-trial-card__updated\">Actualizado el 8 octubre 2026<\/span><\/p><\/article><\/div><nav class=\"aa-trial-pager\" aria-label=\"P\u00e1ginas de la lista de ensayos\"><span aria-current=\"page\" class=\"page-numbers current\">1<\/span><a class=\"page-numbers\" href=\"https:\/\/www.amyloidosisalliance.org\/es\/?t_page=2\">2<\/a><span class=\"page-numbers dots\">&hellip;<\/span><a class=\"page-numbers\" href=\"https:\/\/www.amyloidosisalliance.org\/es\/?t_page=18\">18<\/a><a class=\"next page-numbers\" href=\"https:\/\/www.amyloidosisalliance.org\/es\/?t_page=2\">Siguiente<\/a><\/nav><div class=\"aa-trial-registry\"><p class=\"aa-trial-registry__text\">Esta lista solo incluye los estudios sobre la amiloidosis abiertos o a punto de abrirse. El registro recoge todos los estudios, incluidos los ya finalizados.<\/p><div class=\"wp-block-button aa-btn aa-btn--teal\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">Buscar todos los estudios en ClinicalTrials.gov<span class=\"screen-reader-text\"> (se abre en una nueva pesta\u00f1a)<\/span><\/a><\/div><\/div><p class=\"aa-trial-source\">Fuente: ClinicalTrials.gov (U.S. National Library of Medicine). Lista recuperada por \u00faltima vez el 22 octubre 2026. <a href=\"https:\/\/clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">clinicaltrials.gov<\/a><\/p><\/div><\/div><\/div>\n<\/section>\n\n<section class=\"wp-block-group aa-section aa-section--forest aa-cta is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group aa-inner aa-narrow aa-text-center is-layout-flow wp-block-group-is-layout-flow\">\n<h2 class=\"wp-block-heading\">\u00bfNo sabe por d\u00f3nde empezar?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Nuestras organizaciones miembro conocen a los equipos que realizan estos estudios en su pa\u00eds y pueden ayudarle a preparar la conversaci\u00f3n con su m\u00e9dico.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-aec23bef wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button aa-btn aa-btn--primary\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.amyloidosisalliance.org\/es\/miembros\/\">Encontrar una asociaci\u00f3n cerca de usted<\/a><\/div>\n\n\n\n<div class=\"wp-block-button aa-btn aa-btn--ghost-paper\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.amyloidosisalliance.org\/es\/contacto\/\">Contactar con la Alianza<\/a><\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Inicio\u203aEnsayos cl\u00ednicos Investigaci\u00f3n Ensayos cl\u00ednicos Todos los estudios sobre amiloidosis que est\u00e1n reclutando, van a abrir o reclutan por invitaci\u00f3n, en cualquier parte del mundo, tomados directamente de ClinicalTrials.gov y actualizados cada d\u00eda. Informaci\u00f3n, no consejo m\u00e9dico. La Alianza no dirige estos estudios y no puede inscribirle en ellos. Si un ensayo le parece pertinente, [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2412","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ensayos cl\u00ednicos sobre amiloidosis que reclutan en todo el mundo<\/title>\n<meta name=\"description\" content=\"Todos los estudios sobre amiloidosis que reclutan o van a abrir, procedentes de ClinicalTrials.gov y actualizados a diario. Filtre por tipo, pa\u00eds y estado.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.amyloidosisalliance.org\/es\/ensayos-clinicos\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ensayos cl\u00ednicos sobre amiloidosis que reclutan en todo el mundo\" \/>\n<meta property=\"og:description\" content=\"Todos los estudios sobre amiloidosis que reclutan o van a abrir, procedentes de ClinicalTrials.gov y actualizados a diario. Filtre por tipo, pa\u00eds y estado.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.amyloidosisalliance.org\/es\/ensayos-clinicos\/\" \/>\n<meta property=\"og:site_name\" content=\"Amyloidosis Alliance\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/AmyloidosisAlliance\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-22T13:23:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1707\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@amyloidosisa\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/ensayos-clinicos\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/ensayos-clinicos\\\/\",\"name\":\"Ensayos cl\u00ednicos sobre amiloidosis que reclutan en todo el mundo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/ensayos-clinicos\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/ensayos-clinicos\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\",\"datePublished\":\"2026-09-07T14:16:46+00:00\",\"dateModified\":\"2026-10-22T13:23:26+00:00\",\"description\":\"Todos los estudios sobre amiloidosis que reclutan o van a abrir, procedentes de ClinicalTrials.gov y actualizados a diario. Filtre por tipo, pa\u00eds y estado.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/ensayos-clinicos\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/ensayos-clinicos\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/ensayos-clinicos\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/ensayos-clinicos\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/inicio\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ensayos cl\u00ednicos\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/\",\"name\":\"Amyloidosis Alliance\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#organization\",\"name\":\"Amyloidosis Alliance\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"contentUrl\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/logo.png\",\"width\":252,\"height\":252,\"caption\":\"Amyloidosis Alliance\"},\"image\":{\"@id\":\"https:\\\/\\\/www.amyloidosisalliance.org\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/AmyloidosisAlliance\\\/\",\"https:\\\/\\\/x.com\\\/amyloidosisa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ensayos cl\u00ednicos sobre amiloidosis que reclutan en todo el mundo","description":"Todos los estudios sobre amiloidosis que reclutan o van a abrir, procedentes de ClinicalTrials.gov y actualizados a diario. Filtre por tipo, pa\u00eds y estado.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.amyloidosisalliance.org\/es\/ensayos-clinicos\/","og_locale":"es_ES","og_type":"article","og_title":"Ensayos cl\u00ednicos sobre amiloidosis que reclutan en todo el mundo","og_description":"Todos los estudios sobre amiloidosis que reclutan o van a abrir, procedentes de ClinicalTrials.gov y actualizados a diario. Filtre por tipo, pa\u00eds y estado.","og_url":"https:\/\/www.amyloidosisalliance.org\/es\/ensayos-clinicos\/","og_site_name":"Amyloidosis Alliance","article_publisher":"https:\/\/www.facebook.com\/AmyloidosisAlliance\/","article_modified_time":"2026-10-22T13:23:26+00:00","og_image":[{"width":1707,"height":1707,"url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@amyloidosisa","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.amyloidosisalliance.org\/es\/ensayos-clinicos\/","url":"https:\/\/www.amyloidosisalliance.org\/es\/ensayos-clinicos\/","name":"Ensayos cl\u00ednicos sobre amiloidosis que reclutan en todo el mundo","isPartOf":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/ensayos-clinicos\/#primaryimage"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/ensayos-clinicos\/#primaryimage"},"thumbnailUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg","datePublished":"2026-09-07T14:16:46+00:00","dateModified":"2026-10-22T13:23:26+00:00","description":"Todos los estudios sobre amiloidosis que reclutan o van a abrir, procedentes de ClinicalTrials.gov y actualizados a diario. Filtre por tipo, pa\u00eds y estado.","breadcrumb":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/ensayos-clinicos\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.amyloidosisalliance.org\/es\/ensayos-clinicos\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.amyloidosisalliance.org\/es\/ensayos-clinicos\/#primaryimage","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/hans-reniers-lQGJCMY5qcM-unsplash-scaled-e1788792920766.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.amyloidosisalliance.org\/es\/ensayos-clinicos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.amyloidosisalliance.org\/es\/inicio\/"},{"@type":"ListItem","position":2,"name":"Ensayos cl\u00ednicos"}]},{"@type":"WebSite","@id":"https:\/\/www.amyloidosisalliance.org\/es\/#website","url":"https:\/\/www.amyloidosisalliance.org\/es\/","name":"Amyloidosis Alliance","description":"","publisher":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.amyloidosisalliance.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.amyloidosisalliance.org\/es\/#organization","name":"Amyloidosis Alliance","url":"https:\/\/www.amyloidosisalliance.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.amyloidosisalliance.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","contentUrl":"https:\/\/www.amyloidosisalliance.org\/wp-content\/uploads\/2026\/09\/logo.png","width":252,"height":252,"caption":"Amyloidosis Alliance"},"image":{"@id":"https:\/\/www.amyloidosisalliance.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/AmyloidosisAlliance\/","https:\/\/x.com\/amyloidosisa"]}]}},"_links":{"self":[{"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/pages\/2412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/comments?post=2412"}],"version-history":[{"count":1,"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/pages\/2412\/revisions"}],"predecessor-version":[{"id":2413,"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/pages\/2412\/revisions\/2413"}],"wp:attachment":[{"href":"https:\/\/www.amyloidosisalliance.org\/es\/wp-json\/wp\/v2\/media?parent=2412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}